We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Finance of America Companies
FOA
$198M
| $327K | ﹤0.01% |
25,762
-3,339
| -11% | -$48.9K |
|
2927
Rocky Brands
RCKY
$369M
| $327K | ﹤0.01% |
13,844
| – | – |
|
|
TUYA
2928
Tuya Inc
TUYA
$1.1B
| $325K | ﹤0.01% |
170,400
-129,100
| -43% | -$157K |
|
|
TEAD
2929
Teads Holding Co
TEAD
$67.7M
| $323K | ﹤0.01% |
89,342
-20,263
| -18% | -$79.4K |
|
|
MKFG
2930
DELISTED
Markforged Holding Corporation
MKFG
| $323K | ﹤0.01% |
27,825
-2,362
| -8% | -$36K |
|
2931
Global Water Resources
GWRS
$219M
| $322K | ﹤0.01% |
24,245
| – | – |
|
|
RPTX
2932
DELISTED
Repare Therapeutics
RPTX
| $318K | ﹤0.01% |
21,630
-188
| -0.9% | -$2.81K |
|
2933
Holley
HLLY
$384M
| $317K | ﹤0.01% |
149,592
-432
| -0.3% | -$1.36K |
|
2934
ThredUp
TDUP
$422M
| $316K | ﹤0.01% |
240,906
-267,819
| -53% | -$367K |
|
|
DDL
2935
Dingdong
DDL
$503M
| $311K | ﹤0.01% |
+72,900
| New | +$286K |
|
2936
Humacyte
HUMA
$194M
| $309K | ﹤0.01% |
146,674
+60,828
| +71% | +$185K |
|
2937
Red Violet
RDVT
$924M
| $309K | ﹤0.01% |
13,408
| – | – |
|
2938
Century Therapeutics
IPSC
$361M
| $308K | ﹤0.01% |
60,039
-15,742
| -21% | -$149K |
|
2939
Capital Bancorp
CBNK
$615M
| $307K | ﹤0.01% |
13,029
-11,471
| -47% | -$277K |
|
2940
IBEX
IBEX
$499M
| $306K | ﹤0.01% |
12,317
-3,960
| -24% | -$89.3K |
|
|
FRBK
2941
DELISTED
Republic First Bancorp Inc
FRBK
| $306K | ﹤0.01% |
142,465
-18,968
| -12% | -$50.3K |
|
2942
HighPeak Energy
HPK
$910M
| $305K | ﹤0.01% |
13,333
+199
| +2% | +$4.47K |
|
2943
Focus Universal
FCUV
$3.65M
| $304K | ﹤0.01% |
178
-44
| -20% | -$114K |
|
2944
BRC Inc
BRCC
$250M
| $302K | ﹤0.01% |
49,469
-3,811
| -7% | -$24.9K |
|
2945
Invivyd
IVVD
$218M
| $298K | ﹤0.01% |
198,438
-31,566
| -14% | -$87.8K |
|
|
TIGR
2946
UP Fintech Holding
TIGR
$860M
| $295K | ﹤0.01% |
86,600
-31,200
| -26% | -$135K |
|
2947
Dakota Gold
DC
$804M
| $292K | ﹤0.01% |
95,900
-33,934
| -26% | -$116K |
|
2948
PCB Bancorp
PCB
$391M
| $291K | ﹤0.01% |
16,442
-15,248
| -48% | -$284K |
|
2949
Ouster
OUST
$2.92B
| $288K | ﹤0.01% |
33,314
-8,117
| -20% | -$88.4K |
|
|
LTCH
2950
DELISTED
Latch, Inc. Common Stock
LTCH
| $288K | ﹤0.01% |
406,307
-40,604
| -9% | -$37.2K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.